Sachs Associates would like to say that we have enjoyed hosting you in-person and virtually and thank those who participated in our 18th Annual European Life Sciences CEO Forum (Sachs_ELSF). A special thank you goes to the excellent line-up of sponsors, chairs, panellists, and presenters who made such a broad and interesting programme possible.
The ELSF has proven to be successful in supporting our community with over 430 people from 27 countries registered and nearly 2000 in-person & online meetings completed.
To view the event photo gallery, please navigate to the 'PHOTOS’ tab. To watch a session on-demand, please navigate to the 'RECORDINGS' tab and select the panel or a session that you want to view. To view showcases, please click on the 'PRESENTERS' tab. Each company will have a showcase button, which will allow you to view their presentation. You can still message people and exchange contacts with people you did not have a chance to meet on the Online Meeting System. The Event Portal and meeting system will be available for review and messaging until the 26th of March.
We are looking forward to welcoming you again to our future events!
SILVER SPONSOR:

BRONZE SPONSORS:


CONTRIBUTING SPONSORS:


Presenting Companies Included:
AATec Medical GmbH

ActiTrexx GmbH

Alpioner Therapeutics

Anixa Biosciences, Inc.
ANNIMO Health EDC AG
Anocca AB
Antabio SAS

AVEROA SAS
BioInvent International AB

brainQr Therapeutics GmbH

CNS Pharmaceuticals, Inc.
Convert Pharmaceuticals SA
FluoSphera SA
FoRx Therapeutics AG

HHC Medical

Innovent Biologics

Lead Pharma
LightOx Ltd.
LimmaTech Biologics AG
Mabylon AG
MetrioPharm AG
MicThera SAGL

Minoryx Therapeutics
NatIgGs GmbH
NEC Bio B.V.
OncoBone Therapeutics Ltd
Panntherapi
PhoreMost Ltd.
Procavea Biotech AG
RedHill Biopharma Ltd.
Sapreme Technologies BV
Sarcura GmbH
Scarlet Therapeutics Limited

Spago Nanomedical AB
SpikImm SARL
SpyBiotech Inc.
STIMIT AG

T-knife Therapeutics, Inc.
Telum Therapeutics SL
TME Pharma
VasoDynamics Ltd.
Vectiopep
ViaNautis Bio Ltd.
XYone Therapeutics Inc.
Confirmed Keynote Speakers Included:
DJ
Darren Ji
Co-Founder, Chairman & CEO, Elpiscience Biopharmaceuticals Co. Ltd.
Speakers and Chairs Included:

Esteban Pombo-Villar
Board Member, TargImmune Therapeutics AG
Evonne Sepsis
Managing Director, ESC Advisors
GM
Gregor Macdonald
VP, Head of BD & Licensing, Search & Assessment, H. Lundbeck A/S
Gregory Rall
Deputy Head, Innovation & Technology, InvestHK
KS
Katya Smirnyagina
Senior Partner, Oxford Science Enterprises
MT
Marc-Olivier Turgeon
Senior Associate, Forbion

Michael Hübner
Director Early Innovation Partnering, Johnson & Johnson Innovation LLC
OZ
Olav Zilian
Medical Advisor, FluoSphera SA
OM
Ole Mensching
Co-Founder & General Partner, Apollo Health Ventures
Rainer Strohmenger
Managing Partner, Wellington Partners

Rainer Metzger
Chief Business Officer, Sanavia Oncology
Regina Hodits
Managing Director, Angelini Ventures S.p.A.
Sarah Holland
CBO, CDR-Life AG
Stephanie Léouzon
Managing Director & Vice Chair of European Healthcare Investment Banking, Stifel
SM
Søren Møller
Managing Partner, Novo Holdings A/S
TL
Tim Lohoff
Senior Associate, Forbion

Victoria English
Co-Founder & Editor, Evernow Publishing Ltd, publisher of MedNous
AM
Alain Martelli
Director, External Science Lead, Europe, Pfizer Inc.
AS
Albert Seymour
President & CEO, Seamless Therapeutics, Inc.
AG
Alexander Gebauer
Co-Founder & Executive Chairman, Galimedix Therapeutics, Inc.
AP
Andreas Pahl
CEO, Heidelberg Pharma AG
AG
Anne Grahl
Associate, Pureos Bioventures
AS
Avencia Sanchez-Mejias García
Co-Founder & CEO, Integra Therapeutics
BB
Boris Bogdan
Lead HCLS EMEA, Amazon Web Services
BK
Bryan Kobel
CEO, TC BioPharm Limited

Cem Baydar
Independent Board Member, Strategic Advisor & Investment Officer, Independent - CB
CL
Chandra Leo
Investment Advisor, HBM Partners AG
CB
Charlie Bailey
BD&L Transactions Head, Global Health, Novartis AG
DJ
Darren Ji
Co-Founder, Chairman & CEO, Elpiscience Biopharmaceuticals Co. Ltd.
David Venables
CEO, Laverock Therapeutics Ltd.
DK
Davor Kosanic
CEO, Reconnect Labs AG
DP
Diana Pignalosa
Head of Strategic Partnering, Search & Evaluation, Debiopharm International SA
Esther Melo
Director BD&L, F. Hoffmann-La Roche
GT
George Tzircotis
Associate Director, BD, Cancer Research Horizons
GF
Georgia Frost
Senior Associate, Dementia Discovery Fund 2 L.P. (SV Health Investors)
Jeremy Griggs
Executive Director, Search & Evaluation, GSK
JB
Jesus Baena
BD&L Transactions Oncology Director, Novartis AG
JV
Johannes Virkkunen
Head of Division - Equity Investments, European Investment Fund
KW
Karen Wagner
Managing Partner, Ysios Capital
Katharina Kreymborg
SVP, Curie.Bio
Konstantin Petropoulos
CEO, Secarna Pharmaceuticals GmbH & Co. KG
Laura Lane
VP Lilly Ventures - Head of Europe, Eli Lilly and Company
MM
Marc Martinell
Co-Founder & CEO, Minoryx Therapeutics
MD
Maria Dahl
COO & Head of Europe, Innovent Biologics
Michael Altorfer
CEO, Swiss Biotech Association
MP
Monika Paule
Co-Founder, CEO & Board Member, Caszyme, LLC
NT
Neil Torbett
CEO, PhoreMost Ltd.
NS
Nikolay Savchuk
Managing Partner, Torrey Pines Investment
PD
Paolo Di Giorgio
Managing Director & CEO, Angelini Ventures S.p.A.
PS
Patrick Schwab
Senior Director, AI & Machine Learning, GSK
PV
Paul Vogel
Managing Director & VP of Research, AIRNA Corporation, Inc.
Paul Hermant
Partner, Bird & Bird (Belgium) LLP
PL
Peter Llewellyn-Davies
CEO & CFO, invIOs GmbH
RA
Raj Airey
Founding Partner, Convergence Partners
RJ
Reagan Jarvis
Co-Founder & CEO, Anocca AB
Rd
Robert de Jonge
SVP, Head of Corporate Development, Mestag Therapeutics Ltd.
SK
Sean Kendall
Partner, ARCH Venture Partners
Stephan Lensky
COO & CBO, EpimAb Biotherapeutics
SR
Sylvie Ryckebusch
CBO, BioInvent International AB
Tamas Schweighoffer
Co-Founding Partner, Forty51 Ventures AG
Ted Fjällman
CEO, Flerie Invest AB
Thibaut Roulon
Senior Investment Director, Bpifrance
Thierry Laugel
Managing Partner, Kurma Partners
TS
Thilo Schroeder
Managing Partner, Nextech Invest Ltd.
UW
Ulrich Wendt
Global Head Business Development Immunology & Inflammation, Sanofi
VK
Vanessa King
CEO, King Bioventures
VM
Victor Ma
Partner, Fontaine Capital